Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ Informa to Buy Events Firm from Blackstone for £2.2 Billion (Bloomberg) +++ INFORMA PLC Aktie -4,39%

EMERGENT BIOSOLUTIONS Aktie

 >EMERGENT BIO Aktienkurs 
6.54 EUR    +1.4%    (TradegateBSX)
Ask: 6.675 EUR / 485 Stück
Bid: 6.545 EUR / 495 Stück
Tagesumsatz: 2000 Stück
Realtime Kurs von 7:30 bis 22 Uhr!
EMERGENT BIO Aktie über LYNX handeln
>EMERGENT BIO Performance
1 Woche: -2,0%
1 Monat: +9,5%
3 Monate: -19,7%
6 Monate: -17,1%
1 Jahr: -25,3%
laufendes Jahr: -43,6%
>EMERGENT BIOSOLUTIONS Aktie
Name:  EMERGENT BIOSOLUTIONS
Land:  USA
Sektor:  Gesundheit
ISIN/ Wkn:  US29089Q1058 / A0LC2W
Symbol/ Ticker:  ER4 (Frankfurt) / EBS (NYSE)
Kürzel:  FRA:ER4, ETR:ER4, ER4:GR, NYSE:EBS
Index:  -
Profil:  Emergent BioSolutions Inc. is a life sciences company focused on preparedness and response solutions for accidental, deliberate, and naturally occurring public health threats. Its current business centers on medical countermeasures and specialty prod..
>Volltext..
Marktkapitalisierung:  288.34 Mio. EUR
Unternehmenswert:  679.4 Mio. EUR
Umsatz:  684.26 Mio. EUR
EBITDA:  206.82 Mio. EUR
Nettogewinn:  -157.07 Mio. EUR
Gewinn je Aktie:  -3.06 EUR
Schulden:  522.57 Mio. EUR
Liquide Mittel:  125.18 Mio. EUR
Operativer Cashflow:  86.8 Mio. EUR
Bargeldquote:  1.15
Umsatzwachstum:  -6.71%
Gewinnwachstum:  -230.73%
Dividende je Aktie:  -
Dividendenrendite:  -
Dividendenschätzung:  -
Insiderhandel:  1 Insider verkaufte innerhalb der letzten 30 Tage Aktien im Wert von 17.464 Euro.
Suchwörter:  EMERGENT BIOSOLUTIONS, EMERGENT BIO
Letzte Datenerhebung:  06.10.26
>EMERGENT BIO Kennzahlen
Aktien/ Unternehmen:
Aktien: 51.27 Mio. St.
Frei handelbar: 94%
Rückkaufquote: 10.23%
Mitarbeiter: 900
Umsatz/Mitarb.: 0.73 Mio. EUR
Analysten:
Analystenrating: Buy
Kursziel: 68.77%
Bewertung:
KGV: -
KGV lG: 17.63
KUV: 0.44
KBV: 0.97
PEG-Ratio: -
EV/EBITDA: 3.28
Rentabilität:
Bruttomarge: 47.17%
Gewinnmarge: -22.96%
Operative Marge: 17.77%
Managementeffizenz:
Gesamtkaprendite: -13.95%
Eigenkaprendite: -40.29%
>EMERGENT BIO Peer Group
Gesundheit, Suchtbehandlung (Opium, Alkohol, Nikotin)
 
05.10.26 - 20:24
Pest-Verdachtsfall in Russland beflügelt Aktie von Emergent Biosolutions (Investing.com DE)
 
Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...
05.10.26 - 16:01
Insiderhandel: SVP, Products Business verkauft Aktien von Emergent Biosolutions im Wert von 19590 USD (Insiderkauf)
 
Williams, Paul Anthony - Vorstand - Tag der Transaktion: 2026-10-01...
25.09.26 - 00:45
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Emergent BioSolutions Inc. - EBS (PR Newswire)
 
NEW YORK, Sept. 24, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Emergent BioSolutions Inc. ("Emergent" or the "Company") (NYSE: EBS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The......
14.09.26 - 23:31
Emergent BioSolutions auf Konferenz von H.C. Wainwright: Schulden sinken, Kerngeschäft im Fokus (Investing.com DE)
 
Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...
14.09.26 - 23:30
Emergent BioSolutions restructuring includes 90 job cuts (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
10.09.26 - 16:09
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Emergent BioSolutions Inc. - EBS (PR Newswire)
 
NEW YORK, Sept. 10, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Emergent BioSolutions Inc. ("Emergent" or the "Company") (NYSE: EBS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The......
27.08.26 - 22:33
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Emergent BioSolutions Inc. - EBS (PR Newswire)
 
NEW YORK, Aug. 27, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Emergent BioSolutions Inc. ("Emergent" or the "Company") (NYSE: EBS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The......
18.08.26 - 21:48
Wettbewerbsdruck bei Naloxon: S&P stuft Ausblick für Emergent BioSolutions auf negativ herab (Investing.com DE)
 
Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...
17.08.26 - 16:12
Emergent BioSolutions (EBS) Securities Investigation Notice - Levi & Korsinsky (PR Newswire)
 
Emergent BioSolutions reported approximately $97 million in adjusted EBITDA for the quarter. The same period included a $191.3 million non-cash NARCAN impairment. Levi & Korsinsky is investigating potential securities law violations. NEW YORK, Aug. 17, 2026 /PRNewswire/ -- Emergent......
13.08.26 - 00:24
Emergent BioSolutions (EBS) Q2 2026 Earnings Call Transcript (Fool)
 
MCM deliveries surge but naloxone competition forces restructuring and guidance cuts....
11.08.26 - 16:09
EBS SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving Emergent BioSolutions (PR Newswire)
 
Emergent BioSolutions cut its FY2026 adjusted EBITDA outlook to $130-$150 million from $155-$175 million amid continued NARCAN pricing and margin pressure, with NARCAN gross margin having fallen to 16% in Q1 2026. SueWallSt notifies investors of a pending investigation into potential......
11.08.26 - 00:27
Emergent BioSolutions Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Emergent BioSolutions (EBS) (PR Newswire)
 
Emergent BioSolutions cut FY2026 revenue guidance to $645-$675 million after reaffirming a $720-$760 million outlook three months earlier. Levi & Korsinsky is investigating potential securities law violations. NEW YORK, Aug. 10, 2026 /PRNewswire/ -- Emergent BioSolutions (NYSE: EBS)......
06.08.26 - 17:54
Emergent Bio slips despite Q2 beat amid cost-cutting plan (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
05.08.26 - 23:00
Emergent Biosolutions Non-GAAP EPS of $0.60 beats by $0.49, revenue of $234.3M beats by $56.8M (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
05.08.26 - 22:12
Emergent BioSolutions Reports Second Quarter 2026 Financial Results (GlobeNewswire EN)
 
GAITHERSBURG, Md., Aug. 05, 2026 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today reported financial results for the second quarter ended June 30, 2026....
05.08.26 - 22:12
Emergent BioSolutions Commits to Cross-Sector Collaboration Against Biological Threats in an Evolving Global Security Environment (GlobeNewswire EN)
 
GAITHERSBURG, Md., Aug. 05, 2026 (GLOBE NEWSWIRE) -- Emergent BioSolutions (NYSE:EBS), a global biodefense company, today highlighted the increasing importance of biological threat preparedness as allied nations confront an evolving security environment characterized by geopolitical conflict, artificial intelligence (AI) and synthetic biology and growing concern about the potential misuse of biological agents. Defense and public health leaders are addressing the heightened risks of biological incidents, whether naturally occurring outbreaks, accidental releases or deliberate acts, which represent a critical component of national resilience and security planning....
22.07.26 - 22:03
Emergent BioSolutions to Report Second Quarter 2026 Financial Results on August 5, 2026 (GlobeNewswire EN)
 
GAITHERSBURG, Md., July 22, 2026 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call on Wednesday, August 5, 2026, at 5:00 p.m. eastern time to discuss the financial results for the second quarter of 2026....
02.07.26 - 20:02
Insiderhandel: SVP, Products Business verkauft Aktien von Emergent Biosolutions im Wert von 25200 USD (Insiderkauf)
 
Williams, Paul Anthony - Vorstand - Tag der Transaktion: 2026-07-01...
29.06.26 - 15:15
Emergent BioSolutions Secures Contract Modification Valued at Approximately $52.7 Million for ACAM2000® (Smallpox and Mpox (Vaccinia) Vaccine, Live) from the U.S. Government (GlobeNewswire EN)
 
GAITHERSBURG, Md., June 29, 2026 (GLOBE NEWSWIRE) -- Emergent BioSolutions (NYSE:EBS) today announced it has been awarded a contract modification valued at $52.7 million from the Administration for Strategic Preparedness and Response (ASPR) at the United States Department of Health and Human Services to supply ACAM2000® (Smallpox and Mpox (Vaccinia) Vaccine, Live) vaccine, ancillaries as well as diluent replacement lots for smallpox preparedness and response needs. Deliveries are expected to begin this month....
04.06.26 - 14:03
Emergent BioSolutions Supports Victoria′s Voice Foundation′s National Naloxone Awareness Day to Help Save Lives from Opioid Overdose (GlobeNewswire EN)
 
Efforts focus on increasing awareness, expanding access to lifesaving NARCAN® Nasal Spray and reaching more communities with educational initiatives and resources Efforts focus on increasing awareness, expanding access to lifesaving NARCAN® Nasal Spray and reaching more communities with educational initiatives and resources...
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Philosophen verderben die Sprache, Poeten die Logik, und mit dem Menschenverstand kommt man durchs Leben nicht mehr. - Friedrich Johann Christoph Schiller
>Aktienauflistung | >Aktienscreener | >Aktienkennzahlen | >Anleihen | >ETFs | >Fonds | >Branchen | >Länder | >Themen | >Redaktionen
Partner:    >TradegateBSX Börse | >Dukascopy | >TradingView | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!